Aehr Test Systems (NASDAQ:AEHR) Issues FY 2024 Earnings Guidance

Aehr Test Systems (NASDAQ:AEHRGet Free Report) updated its FY 2024 earnings guidance on Monday. The company provided EPS guidance of 0.480- for the period, compared to the consensus EPS estimate of 0.760. The company issued revenue guidance of $65.0 million-$65.0 million, compared to the consensus revenue estimate of $77.4 million. Aehr Test Systems also updated its Q3 2024 guidance to -0.040–0.030 EPS.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. William Blair reaffirmed a market perform rating on shares of Aehr Test Systems in a research note on Monday. StockNews.com raised shares of Aehr Test Systems from a sell rating to a hold rating in a research note on Friday, January 19th.

Read Our Latest Report on Aehr Test Systems

Aehr Test Systems Price Performance

AEHR stock opened at $11.37 on Tuesday. Aehr Test Systems has a 12 month low of $10.53 and a 12 month high of $54.10. The firm has a market cap of $328.02 million, a PE ratio of 16.01 and a beta of 2.01. The firm has a 50 day simple moving average of $16.13 and a 200 day simple moving average of $25.88.

Aehr Test Systems (NASDAQ:AEHRGet Free Report) last released its earnings results on Tuesday, January 9th. The semiconductor company reported $0.20 EPS for the quarter, beating the consensus estimate of $0.16 by $0.04. Aehr Test Systems had a net margin of 25.76% and a return on equity of 26.97%. The business had revenue of $21.43 million during the quarter, compared to analyst estimates of $20.10 million. As a group, sell-side analysts expect that Aehr Test Systems will post 0.72 earnings per share for the current year.

Insider Activity at Aehr Test Systems

In other news, VP Avijit K. Ray-Chaudhuri purchased 3,000 shares of Aehr Test Systems stock in a transaction that occurred on Friday, January 12th. The stock was acquired at an average price of $17.87 per share, for a total transaction of $53,610.00. Following the transaction, the vice president now owns 9,719 shares in the company, valued at $173,678.53. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, CEO Gayn Erickson sold 4,871 shares of the stock in a transaction on Thursday, January 18th. The shares were sold at an average price of $17.39, for a total transaction of $84,706.69. Following the transaction, the chief executive officer now owns 427,935 shares in the company, valued at approximately $7,441,789.65. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, VP Avijit K. Ray-Chaudhuri purchased 3,000 shares of the company’s stock in a transaction dated Friday, January 12th. The shares were acquired at an average price of $17.87 per share, for a total transaction of $53,610.00. Following the purchase, the vice president now owns 9,719 shares in the company, valued at $173,678.53. The disclosure for this purchase can be found here. In the last 90 days, insiders sold 8,738 shares of company stock worth $151,723. 6.30% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Lazard Asset Management LLC acquired a new position in shares of Aehr Test Systems during the 4th quarter worth $34,000. Deutsche Bank AG acquired a new position in shares of Aehr Test Systems during the 1st quarter worth $40,000. PNC Financial Services Group Inc. boosted its holdings in shares of Aehr Test Systems by 93.0% during the 2nd quarter. PNC Financial Services Group Inc. now owns 1,158 shares of the semiconductor company’s stock worth $48,000 after buying an additional 558 shares during the period. Citigroup Inc. boosted its holdings in shares of Aehr Test Systems by 463.8% during the 4th quarter. Citigroup Inc. now owns 2,458 shares of the semiconductor company’s stock worth $49,000 after buying an additional 2,022 shares during the period. Finally, JPMorgan Chase & Co. boosted its holdings in shares of Aehr Test Systems by 1,027.1% during the 1st quarter. JPMorgan Chase & Co. now owns 1,578 shares of the semiconductor company’s stock worth $49,000 after buying an additional 1,438 shares during the period. Institutional investors and hedge funds own 69.69% of the company’s stock.

Aehr Test Systems Company Profile

(Get Free Report)

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.

See Also

Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.